Propionyl-L-carnitine Propionyl-L-carnitine is not approved by the US FDA for use as a drug to prevent or treat any condition
Combined administration of bezafibrate and the dipeptidyl peptidase-4 inhibitor des-fluoro-sitagliptin improved glucose tolerance, islet architecture and beta cell mass in db/db mice, whereas either compound alone had no effect
(PubMed) Spitz MR, Duphorne CM, Detry MA, et al
But she adds that not all doctors are confident the drug works and getting coverage for it will be difficult
For women who need to lose weight before becoming eligible for IVF, Mounjaro can be part of an effective weight loss plan
Regenerative Biomaterials , Volume 4, Issue 3, June 2017, Pages 191206